-transparent.png){kind=logo}
The effect of methysergide (MES), a serotoninergic antagonist on prolactin (PRL) blood levels was studied in five hyperprolactinemic amenorrheic women. The drug was administered for five days at a daily dosage of 11.2 mg. MES decreased significantly the PRL blood levels in all subjects (p less than 0.01). Since the MES has been shown to have antiserotoninergic effects and since serotonin has been thought to be involved in the control of PRL release, the effects of MES in lowering PRL might be due to a decrease of serotonin tone.
Related Publications
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
September 1997,
Fertility and sterility,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
May 2000,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1980,
Annales d'endocrinologie,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
April 1999,
Clinical chemistry and laboratory medicine,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
October 1987,
Endocrinologia japonica,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1987,
The Journal of reproductive medicine,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1980,
Endocrine reviews,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1993,
Revista chilena de obstetricia y ginecologia,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1977,
Acta obstetricia et gynecologica Scandinavica,
R D'Agata, and
S Ando, and
L Iachello, and
V Pezzino, and
S Gulizia, and
U Scapagnini
January 1995,
Journal of basic and clinical physiology and pharmacology,
